Format

Send to

Choose Destination
Bioorg Med Chem Lett. 2002 Aug 5;12(15):2023-6.

4-Aminoarylguanidine and 4-aminobenzamidine derivatives as potent and selective urokinase-type plasminogen activator inhibitors.

Author information

1
Celera, 180 Kimball Way, South San Francisco, CA 94080, USA.

Abstract

The structure-based design of potent and selective urokinase-type plasminogen activator (uPA) inhibitors with 4-aminoarylamidine or 4-aminoarylguanidine S1 binding groups, is described.

PMID:
12113833
DOI:
10.1016/s0960-894x(02)00312-8
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center